References
- Farley T MM, Rowe P J, Rosenberg M J, et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339: 785–8
- Andersson K, Ryde-Blomqvist E, Lindell K, et al. Perforations with intrauterine devices. Report from a Swedish survey. Contraception 1998; 57: 251–5
- Meirik O, Farley T MM, Sivin I. Safety and efficacy of levonorgestrel implant. Intrauterine device, and sterilization. Obstet Gynecol 2001; 97: 539–47
- Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 μg/d and the Copper Tcu 380Ag intrauterine contraceptive devices: a multicenter study. Fertil Steril 1994; 61: 70–7
- Newton J, Tacchi D. Long-term use of copper intrauterine devices. Lancet 1990; 336: 1322–3
- UNDP/UNPF/WHO/World Bank. Special Programme of Research, Development and Research Training in Human Reproduction. Long-term reversible contraception: twelve years of experience with the Tcu 380A and Tcu220C. Contraception 1997; 56: 341–52
- Toivonen J, Luukkainen T, Allonen H. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years comparative experience of levonorgestrel-and copper-releasing intrauterine devices. Obstet Gynecol 1991; 77: 261–4
- Sivin I. Dose-and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol 1991; 78: 291–8
- Van Weel C. Validating long-term morbidity recording. J Epidemiol Community Health 1995; 49(Suppl 1)29–32
- Van den Bosch W, Huygen F, van den Hoogen H, van Weel C. Morbidity in early childhood: Family patterns in relation to sex, birth order and social class. Fam Med 1993; 25: 126–30
- Cole L P, Potts D M, Aranda C, et al. An evaluation of the TCu 380 Ag and the Multiload Cu 375. Fertil Steril 1985; 43: 214–7
- Siddle N. Risks of intrauterine contraceptive devices. Br Med J 1984; 128: 1279–81
- Van der Velden J, de Bakker D H, Claesens A AMC, Schellevis F G. A national study for diseases and procedures in general practice. Basic survey: Morbidity in general practice, , et al. NIVEL, Utrecht 1991
- NHG-protocol ‘the IUD’ (1st revision). Huisarts Wet 2000; 43: 314–20
- Datey S, Gaur L N, Saxena B N. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)-An Indian experience. Contraception 1995; 51: 155–65
- Luukkainen T, Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception 1995; 52: 269–76
- Fedele L, Bianchi S, Zanconato G, et al. Use of a levonorgestrelreleasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001; 75: 485–8
- Diaz J, Bahamondes L, Monteiro I, et al. Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena) in Campinas, Brazil. Contraception 2000; 62: 59–61
- Rivera R, Chen-Kok M, McMullen S. Analysis of client characteristics that may affect early discontinuation of the Tcu380A IUD. Contraception 1999; 60: 155–60
- Bracher M, Santow G. Premature discontinuation of contraception in Australia. Fam Plann Perspect 1992; 24: 58–65
- Rosenberg M J, Foldesy R, Mishell D R, et al. Performance of the Tcu380A and Cu-Fix IUDs in an international randomized trial. Contraception 1996; 53: 197–203
- Mishell D R. Intrauterine devices: mechanisms of action, safety and efficacy. Contraception 1998; 58: 45S–53S